Taiho Oncology CEO Tim Whitten: Building Upon Lonsurf, Inqovi

 
• By Joseph Haas
  
Drug_Design
Otsuka affiliate Taiho has high expectations for its cholangiocarcinoma drug
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business